dialcat : diabet acceler cognit impair alzheim  diseas , comprehens approach adher treatmentreto dialcat : diabet acceler cognit impair alzheim  diseas , comprehens approach adher treatment cristian barrue1 , roger vila1 , antonio b. martinez1 , mario martn1 , javier vazquez-salceda1 rafael simo2,4 , marta barroso1 , ulis cortes1,3 1 universitat politecnica de catalunya , comput scienc depart , barcelona , spain 2 vall  hebron institut de recerca ( vhir ) , barcelona , spain 3 barcelona supercomput center , barcelona , spain 4 ciberdem ( instituto de salud carlo iii ) , barcelona , spain { cbarru , mbarroso } @ cs.upc.edu , rafael.simo @ vhir.org abstract .
articl , present design mhealth system support senior citizen chronic diseas manag adher pharmacolog treatment .
dialcat system consist smart pill dispens mobil applic test clinic studi 18 month patient suffer diabet mild cognit impair .
clinic trial aim studi effect diabet acceler cognit impair alzheim  diseas impact adher treatment .
dialcat ris3cat project co-fund european erdf programm .
keyword .
ehealth , activ assist live , diabet , mild cognit impair , treatment adher- enc , mhealth .
1 introduct accord world health organis [ 41 ] , 47m peopl around world form dementia , effect intervent , halt revers progress cognit impair .
europ  popul age , long-term care elder citizen becom increas cost societi .
manag transit healthcar polici eu individu member state heavili focus extend independ life elder , dual aim increas qualiti life ( qol ) reduc cost care .
time exist enough robust epidemiolog data [ 35 ] show patient diabet mellitus type 2 ( dm2 ) present 2-3 preval sever cognit impair alzheim  diseas ( ad ) general popul compar age .
circumst pose sever social health problem .
popul generat bill approxim 5,500 million euro spain  healthcar system .
diabet patient mild cognit im- pairment ( mci ) group particular predisposit develop ad general compos polymed patient .
moreov , cognit impair may impli kind computacin sistema , vol .
23 , .
2 , 2019 , pp .
351363 doi : 10.13053/cys-23-2-3198 issn 2007-9737 patient , among thing , lack treatment adher error drug manag may serious consequ .
treatment adher understood , measur person  action - medicin intak , follow diet , and/or implement lifestyl chang - correspond health profession  recommend .
undeni mani patient difficulti follow recommend doctor , sever compromis effect treatment creat critic problem health qol point view well econom term .
dm2 patient paradigm polymed- icat patient , also , present certain degre cognit declin , forget mis- take drug manag increas signific [ 37 ] .
provid mean facilit increas adher theoret treatment tremend social-sanitari impact .
dialcat project initi fund european erdf programm propos comprehens multidisciplinari approach problem includ observ clinic research pilot intervent studi improv metabol control dm2 patient mci .
one object project improv treatment adher patient detect possibl advers effect may aris polymed , particular , decreas metabol control , intervent clinic trial ultim goal avoid delay much possibl appear ad .
dialcat propos innov element , develop valid electron drug dispens allow adher support monitor .
devic integr mhealth applic develop valid trial facilit treatment manag patient caregiv interact direct involv stakehold ( clinician pharmacist ) order increas concord , consequ , effici improv metabol control .
paper focus descript dialcat  mhealth system intervent pilot studi .
1.1 plan work plan paper follow , section 2 detail treatment adher problem , section 3 address relat work explain relev ehealth platform implement give support treatment adher .
section 4 develop dialcatarchitectur , deploy goal .
section 5 explain object pilot studi give insight inform dialcat stakehold .
section 6 devot discuss conclus comment futur work .
2 adher chronic diseas signific grow problem popul .
far lead caus mortal , repres 86 % death eu .
adher long-term therapi chronic ill develop countri averag 50 % .
develop countri , rate even lower .
undeni mani patient experi difficulti follow treatment recommend [ 40 ] .
individu suffer one ( ) chronic diseas receiv complex polypharmaci therapi .
high pill burden decreas adher drug therapi , result need take larg number pill form medic regular basi .
adher rate typic higher patient acut condit , compar chronic condit , adher drop dramat first six month therapi [ 26 ] prophylaxi .
poor adher long-term therapi sever compromis effect treatment mak- ing critic issu popul health perspect qualiti life health econom .
treatment non-adher consid signific health care problem .
fact especi true patient chronic ill adher crucial factor effect therapi [ 6 ] .
concord adher manag high prioriti , signific effect cost-effect therapi .
computacin sistema , vol .
23 , .
2 , 2019 , pp .
351363 doi : 10.13053/cys-23-2-3198 cristian barru , roger vila , antonio b. martinez , mario martn , javier vzquez salceda , rafael sim , et al.352 issn 2007-9737 especi import disord high healthcar cost , oncolog diseas , psychiatr disord , hiv , geriatrician disord dementia .
initi attempt address medicin non-adher promot patient involv treatment deci- sion , singl intervent strategi packag strategi shown effect across patient , condit set .
abil patient follow treatment plan optim frequent compromis one barrier , usual relat differ aspect problem .
includ social econom factor , healthcar team/system , characterist diseas therapi patient-rel factor [ 40 ] .
trosl defin non-adher  unavoid by-product collis clinic world compet world work , play , friendship famili life  [ 39 ] .
intervent use appli high-technolog show potenti support therapi adher patient diseas requir polypharmacolog treatment .
pharmacist care could help reach optim cooper patient , healthcar profession use high technolog intervent , one main object improv rate patient adher long-term therapi .
treatment non-adher expens potenti dead problem , result 89,000 death 100 billion us dollar per year unnecessari hospit cost , usa .
estim 194,500 death year eu due miss-dos non-adher prescrib medic [ 27 ] .
non-adher estim cost european union 125be annual [ 27 ] .
unus medic return uk inciner .
uk alon 10 % drug wast inciner year , valu 369.6 .
studi consist find signific cost-sav increas effect health intervent attribut intervent improv adher [ 36 ] .
without system address deter- minant adher , advanc biomed technolog fail realis potenti reduc burden chronic ill .
intervent target adher must tailor particular illness-rel demand experienc patient , main care need chronic condit base patient self-manag ( usual requir complex multi- therapi ) chang lifestyl .
3 relat work despit technic advanc telehealth , sensor , cognit system social network , system control medic non-adher still integr embed care process , especi medic adher fulfil assess home .
3.1 method assess adher accur assess adher behaviour necessari effect effici treatment plan , ensur chang health outcom attribut recommend regimen .
indisput , gold standard measur adher behaviour [ 9 ] .
tradit adher assess method one find standard clinic practic often yield inaccuraci use standalon method [ 16 ] .
three main approach : patient caregiv self-report , review refil record pill count .
pharmacist assess use question would includ self-report method .
1 .
self-report : clinician tradit reli upon self-report assess medic adher treatment .
visit , pa- tient/caregiv ask set direct ques- tion regard medic use treatment concord ( e.g .
diet , physic activ , etc . ) .
time user answer posit even fals , avoid alien provid discomfort share difficulti associ medic use .
interview method proven less reliabl [ 10 ] .
altern interview method obtain inform [ 33 ] consist formul open-end question like tell take medic ? .
exampl computacin sistema , vol .
23 , .
2 , 2019 , pp .
351363 doi : 10.13053/cys-23-2-3198 dialcat : diabet acceler cognit impair alzheim  diseas ... 353 issn 2007-9737 self-assess valid clinic screen tool moriski scale [ 24 ] .
2 .
prescript refil method : partial use assess medic adher patient purchas medic singl sourc electron recip avail allow track purchas .
inform obtain like general inadequ [ 11 ] obtain inform refil , prescript renew provid inform real consumpt .
3 .
pill count : although consid use method assess adher , proven unreli , tend overestim adher [ 31 ] .
3.2 type non-adher treatment non-adher caus vari among patient broad categoris uninten- tional intent .
unintent non-adher involv intend take medic follow treatment pattern instruct fail reason ( e.g .
forget , careless ) .
unintent non-adher influenc patient characterist , treatment factor patient-provid issu .
contrast , intent non-adher involv make reason deci- sion follow treatment instruct base percept , feel belief .
intent non-adher reflect ration decision-mak process patient wherebi benefit treatment weigh advers effect treatment .
broad characteris non-adher may oversimplifi complex involv non-adher , practic illustr mitig non-adher requir differ intervent .
3.3 non-ict medic manag assess tool sever scale assess tool design evalu patient  medic manag skill .
scale cover differ aspect relat adher medic process instanc :  abil read understand label proper .
 abil open , withdraw proper amount medic close medic contain .
 abil understand medic regimen requir .
 abil follow correct time food/liquid co-ingest indic .
valid scale found least one physic depend activ daili live cognit impair independ risk factor poorer perform [ 16 ] .
thorough review studi tool assess medic manag skill perform 44 differ instrument ( 26 invalid , 18 valid ) show skill assess , method assess , high variabl [ 8 ] .
valid instrument use standardis , simul medic regi- men , wherea invalid instrument most use patient  medic inadequ detail instruct enabl standardis administr .
conclud , said reliabl standard scale tool measur patient adher abil manag medic wide accept recommend clinic best-practis guidelin .
mani differ measur report literatur , substanti variat studi design definit report suggest need increas standardis terminolog definit measur adher persist allow comparison across studi [ 1 ] .
3.4 ict aid adher assess sever solut exist support medic adher ; relat low technolog meth- od ( e.g .
pill box , pill count ) adher assess common use , newer ict tool develop .
includ autom pill dispens , refil remind intak remind telehealth approach .
computacin sistema , vol .
23 , .
2 , 2019 , pp .
351363 doi : 10.13053/cys-23-2-3198 cristian barru , roger vila , antonio b. martinez , mario martn , javier vzquez salceda , rafael sim , et al.354 issn 2007-9737 pill dispens dozen solut avail market , simpl low cost complex expens .
classifi three categori :  passiv : passiv pill dispens includ low technolog solut pillbox enact storag role adher process .
mani solut market , classifi medic sever dose , along week day eas intak .
storag style help remind pill correspond intak , contribut medic adher complet unproven .
 remind : remind categori find lowest technolog profil pill box attach alarm clock alert user take medic ( medglid [ 17 ] , med-q [ 20 ] , med-tim [ 26 ] )  smart : categori , find devic capac includ previous one , extra element provid advanc servic .
instanc , phillip medic dispens servic [ 28 ] retir miss dose left tray , provid instruct take medicin resist energi failur .
pillo [ 30 ] , offer facial recognit , remind possibl share dispens activ famili caregiv via internet .
ict technolog relat adher- enc support target pharmacist like medic dispens [ 18 ] support prepar person medic blister .
[ 23 ] explor pill dispens associ multi-ag system abl provid alert interact differ actor .
differ solut present among mani technolog aid design help patient adher medic schedul , current market direct patient caregiv .
design patient friend low cost , technolog aid support adequ reliabl valid data [ 16 ] .
control trial compar system convent method lack .
patent search perform use european patent offic engin use keyword like treatment adher pill dispens author got 800 hit .
patent group pill cap medicin bottl ( alarm counter ) , industri machin pharmaci industri , protect case pill blister , manual devic blister pill extract , pill count display mechan pill dispens .
mobil app social network market , mani softwar solut orient mobil phone .
applic provid program remind dosag configura- tion medic ( pillboxi [ 29 ] ) , remind appoint doctor incorpor contact phone ( med  clock [ 19 ] ) includ complex servic regard health manag ( myquest patient [ 25 ] ) .
studi present dayer [ 5 ] smartphon medic adher app examin 160 adher app show app go beyond classic remind provid enhanc servic like complex treatment instruct , onlin databas provid data entri .
medic adher tool also reach social network , instanc , crohnolog social network gather togeth stakehold contribut treatment crohn diseas .
caregiverspro-mmd [ 7 ] social network support peopl live dementia caregiv , also provid treatment adher support featur .
work focus evalu effect medic remind young individu avail social network [ 21 ] .
osteolink [ 15 ] aal fund project explor use social network connect patient care provid osteoporosi context .
practic social support consist associ greater medic adher [ 34 ] , studi associ greater adher use social network need .
computacin sistema , vol .
23 , .
2 , 2019 , pp .
351363 doi : 10.13053/cys-23-2-3198 dialcat : diabet acceler cognit impair alzheim  diseas ... 355 issn 2007-9737 fig .
1 .
dialcat architectur eu fund project mani eu fund project use telehealth platform monitor specif patholog , offer medic adher check use self-report ( chronius [ 3 ] , comoesta [ 4 ] , heartcycl [ 12 ] , monarca [ 22 ] ) .
project focus improv adher treatment , use ict like hivind [ 13 ] project tri improv adher hiv treatment use mobil phone messag use ict focus develop new best-practic medic trial ( quatro [ 32 ] , improvingadher [ 14 ] , abc [ 2 ] ) .
medic [ 38 ] project includ use ict base pill dispens improv adher studi , result product never reach actual standard neither reach market .
4 dialcat mhealth platform dialcat project propos develop innov mhealth platform well-tailor personalis servic substanti improv chronic patient  medic treatment adher- enc ( see architectur figur 1 ) .
dialcat platform incorpor two element : ) smart pill dispens develop provid medic prescrib time , control miss dose includ sensor , control drug stock provid characterist iot devic ; ii ) dialcat mobil app empow user abil self manag treatment obtain tailor inform feedback depend treatment concord .
dialcat offer user opportun self-manag personalis therapeut programm medic supervis home use dialcat platform .
lead patient achiev treatment goal ( ) prefer environ , improv motiv , provid object assess personalis protocol outcom process .
furthermor , may provid uniqu opportun gather larg amount data adher therapeut regimen outcom extend period time , share computacin sistema , vol .
23 , .
2 , 2019 , pp .
351363 doi : 10.13053/cys-23-2-3198 cristian barru , roger vila , antonio b. martinez , mario martn , javier vzquez salceda , rafael sim , et al.356 issn 2007-9737 increas knowledg user  lifestyl evolut , predict potenti risk benefit avoid cold start effect new user start use dialcat platform .
dialcat platform abl provid time precis indic patient adher produc relev report help clinician improv personalis treatment react necessari .
4.1 dialcat smart pill dispens dialcat  smart pill dispens set capabl make differ avail market beyond fact connect dialcat system feed user  adher data .
dispens allow manag follow :  drug need provid specif time place .
 drug provid belong user link dispens .
 inform pill remov specif cell record .
devic design work home environ need refil week .
drug refil servic perform train pharmacist , current common practic spanish health system instanc , also perform train user .
technolog barrier use devic low make usabl kind user .
design devic alway consid use low-cost materi make afford mani peopl possibl reach commerci phase .
main capabl devic :  remind : devic warn user time pill in-tak along day .
first blink light later also use acoust alarm end in-tak time slot get closer .
connect mhealth platform provid updat inform drug in-tak schedul ; remind dynam generat depend treatment chang .
 7  4 system : devic 28 pill cell , seven row per weekday four slot per day standard in-tak dose ( breakfast , lunch , dinner , night ) .
devic uniqu identifi user link dialcat mhealth platform get inform treatment .
drug store follow european standard medic contain isol .
 adher control : instal sensor base ir led technolog allow detect pill guarante precis 5mm .
cell control set sensor control presenc pill ( see figur 2 ) .
sensor allow dialcat dispens detect mani time along day user take pill devic happen .
 stock control : sensor box allow control everi moment status devic , control cell empti .
allow detect wrong in-tak ( empti cell certain moment ) need refil devic soon , allow alert user proper appoint servic provid .
 sound : devic provid mean continu offer servic , even electr power avail ( thank includ batteri ) internet connect fail .
case , devic alway allow user retriev medic .
inform store , sent condit allow keep mhealth platform updat .
figur 3 see firmwar flux diagram normal oper dispens .
design , prototyp intern valid phase , devic actual product phase .
project pilot studi , 140 unit assembl time write paper .
computacin sistema , vol .
23 , .
2 , 2019 , pp .
351363 doi : 10.13053/cys-23-2-3198 dialcat : diabet acceler cognit impair alzheim  diseas ... 357 issn 2007-9737 fig .
2 .
ir sensor screen cell 4.2 dialcat mobil app mhealth platform allow integr inform come extern devic smart dispens ( e.g .
glucomet ) inform generat platform interact patient connect differ actor therapeut process : patient , doctor , caregiv pharmacist .
order establish communic , addit digit platform integr data collect automat , control panel doctor caregiv develop , enabl interact inform exchang regard therapi .
applic allow doctor contact patient time contact doctor patient , allow flexibl flow inform clinic real time avail today .
authoris caregivers/rel connect platform inform monitor patient  health , adher treatment evolut therapi .
end cycl , find pharmacist connect patient doctor receiv order replenish medic dispens valid treatment schedul specif patient .
control panel , abl check medic load dispens patient well contain dispens ( e.g .
suppositori , inject , syrup , etc . ) .
even contain dispens , devic remind user take .
addit platform doctor , mobil applic allow patient caregiv give feedback follow-up therapi answer questionnair pharmacolog treatment , lifestyl , diet , exercis , etc .
inform transpar integr platform generat statist report avail clinician .
platform also allow provid remind treatment motiv messag continu adher treatment .
monitor also report unexpect effect ( main due drug-drug interact polymed context ) , system analys possibl action mechan explain effect .
special advers effect relat decreas metabol control particular import .
main featur dialcat digit platform :  communic channel therapeut process stakehold format chat system  control panel manag patient  medic  report system adher health variabl ( i.e .
glycemia )  adher support system use re- minder personalis messag  questionnair system collect health data patient ( i.e .
glycemia measur )  integr servic extern devic like smart dispens glucomet use api  easi intuit user experi 5 dialcat studi overal object evalu whether improv metabol control hypertens promot adher treatment communic patient medic equip prevent delay process cognit declin convers ad diabet patient mci .
intervent computacin sistema , vol .
23 , .
2 , 2019 , pp .
351363 doi : 10.13053/cys-23-2-3198 cristian barru , roger vila , antonio b. martinez , mario martn , javier vzquez salceda , rafael sim , et al.358 issn 2007-9737 fig .
3 .
dialcat main algorithm computacin sistema , vol .
23 , .
2 , 2019 , pp .
351363 doi : 10.13053/cys-23-2-3198 dialcat : diabet acceler cognit impair alzheim  diseas ... 359 issn 2007-9737 appli studi dialcat digit platform compos smart pill dispens mhealth platform .
studi begin begin 2019 .
studi design : control clinic trial , prospect , randomis parallel group .
studi regist clinic trial.gov.registri .
primari object : evalu effect intervent progress cognit impair 1 elder popul ( 60-79 year ) dm2 mci .
secondari object : 1 .
evalu intervent mention improv metabol control .
2 .
evalu effect intervent convers rate mci ad .
3 .
compar effect intervent reduc memori drop convers rate ad .
4 .
identifi clinic analyt predictor ( biomark ) convers mci ad .
particip : patient dm2 mci ( n = 174 ) follow 18 month .
particip includ hospit center particip project ( vall  hebron institut de recerca , parc sanitari pere virgili , fundacio althaia , fundacio univesitaria del bage , consorci sanitari de terrassa , fundacio privada hospit asil de granol , consorci hospitalari de vic , fundacio docencia recerca mutua de terrassa ) .
general clinic variabl evalu : general clinic variabl analyz follow : age , gender , ethnic , educ , anthropometr measur ( bodi mass index waist circumfer ) , presenc cardiovascular risk factor ( hypertens , dyslipidemia , smoke ) , alcohol consumpt , 1assess memori test includ cognit batteri pharmacolog treatment famili histori dementia .
relat dm2 , follow variabl also record : type time evolut diabet , metabol control data ( basal glycaemia hba1c ) presenc absenc complic diabet : retinopathi , nephropathi , neuropathi cardiovascular diseas ( ischem heart diseas , stroke peripher arteriopathi ) .
inclus criteria : 1 ) durat diabet least 5 year .
2 ) age 60 75 year .
3 ) mci ( defin criteria ) .
exclus criteria : 1 ) ad anteced .
2 ) patient type dementia .
3 ) histori neurolog psychiatr condit substanti affect cognit , produc sensori impair mobil limit may prevent restrict applic evalu intervent , well import health problem ( exampl , recent cardiovascular event clinic relev , renal diseas , oncolog treatment ) .
random : patient elig dm2 randomis 1 : 1 : 1 ratio one three branch .
alloc treatment base comput random generat list link singl number treatment .
randomis , sex-by-sex-swap sequenc apo genotyp use .
given sever factor expect synergist effect , effect cumul intervent studi 3 parallel arm follow intervent appli : group : dm2 patient ( n = 58 ) mci receiv treatment recommend primari / endocrinologist .
group b : dm2 patient ( n = 58 ) mci apart standard treatment enjoy dialcat smart dispens allow support monitor treatment adher .
computacin sistema , vol .
23 , .
2 , 2019 , pp .
351363 doi : 10.13053/cys-23-2-3198 cristian barru , roger vila , antonio b. martinez , mario martn , javier vzquez salceda , rafael sim , et al.360 issn 2007-9737 group c : dm2 patient ( n = 58 ) mci , addit dispens , receiv period feedback metabol control improv medic devic via dialcat mhealth digit platform .
abil possibl use necessari technolog support ( tablet platform ) criterion exclus assign one group .
case , taken account level statist analysi , main done intent treat .
given expect differ factor addit synergist effect , hypothesi cognit impair progress mci ad would : group 1 > group 2 > group 3 .
inform consent secur monitor : inform consent obtain subject , centr  ethic committe evalu studi approv .
6 conclus futur work senior cognit impair feel great need public awar diseas support caregiv .
treatment revers halt diseas progress avail dementia , forese futur , treatment medic dementia remain centr entir diseas manag .
slow rate cognit declin earli diagnosi essenti give patient best chanc maintain cognit abil .
dialcat offer potenti solv patient  non-adher encourag self-manag treatment make possibl continu therapeut regimen , reduc cost patient , caregiv health system .
improv treatment adher develop target intervent mhealth platform channel , crucial address specif reason patient abl will execut treatment plan .
perspect , intervent messag personalis tailor address individu need belief .
definit tailor describ featur make tailor health messag differ approach : assessment-bas , result , messag individual-focus .
word , tailor base gather assess person data relat health outcom sever determin order determin effect strategi meet personatm need .
characterist , tailor messag provid person feedback , command greater attent , process deepli , perceiv likeabl patient general messag .
possibl , tailor health messag also like generic inform read , rememb , view person relev .
technolog like smart pill dispens potenti use data generat process actor health ecosystem .
moreov , integr health data collect mhealth applic standard clinic health record , provid holist view patient  treatment concord support tool improv decis make .
next step dialcat project finalis industri product 140 smart dispens unit start clinic trial januari 2019 .
month data collect , consortium abl process start use machin learn techniqu cluster differ type patient regard adher detect connect adher rate diseas evolut .
clinic valid ict adher support system propos dialcat leap ahead design kind technolog .
moreov , consortium abl compar adher rate detect dialcat platform one generat typic clinic adher scale ( e.g .
moriski [ 24 ] ) includ dialcat  clinic trial screen process .
computacin sistema , vol .
23 , .
2 , 2019 , pp .
351363 doi : 10.13053/cys-23-2-3198 dialcat : diabet acceler cognit impair alzheim  diseas ... 361 issn 2007-9737 acknowledg author partial support project dialcat : diabet acceler cognit impair alzheim  diseas , comprehen- sive approach adher treatment ( dia ) co-fund european region develop fund ( erdf ) european union , within oper erdf catalonian framework 2014-2020 .
view express paper necessarili consortium cmmd .
prof. cort member sistema nacion de investigador ( sni-iii ) , ( conacyt , mexico ) .
refer 1 .
andrad , s. e. , kahler , k. h. , frech , f. , & chan , k. .
( 2006 ) .
method evalu medic adher persist use autom databas .
pharmacoepidemiolog drug safeti , vol .
15 , .
8 , pp .
565574 .
2 .
ascertain barrier complianc : polici safe , effect cost-effect use medicin europ ( abc ) ( 2012 ) .
https : //cordis.europa.eu/project/rcn/88878/ factsheet/en .
3 .
chronius ( 2012 ) .
http : //www.chronious.eu/ .
4 .
comoesta ( 2010 ) .
https : //cordis.europa .
eu/project/rcn/85409/factsheet/en .
5 .
dayer , l. , heldenbrand , s. , anderson , p. , gubbin , p. o. , & martin , b. c. ( 2013 ) .
smartphon medic adher app : potenti benefit patient provid .
journal american pharmacist associ , vol .
53 , .
2 , pp .
172181 .
6 .
dimatteo , m. ( 2004 ) .
variat patient  adher- enc medic recommend : quantit review 50 year research .
medic care , vol .
42 , .
3 , pp .
200209 .
7 .
dunn , r. , zafeiridi , p. , wolverson , e. , & paulson , k. ( 2016 ) .
consult end-us design usabl caregiverspro-mmd : internet base support tool design peopl dementia caregiv .
alzheim europa , pp .
po3.29 .
8 .
elliott , r. .
& marriott , j. l. ( 2010 ) .
review instrument use clinic practic assess patient  abil manag medic .
journal pharmaci practic research , vol .
40 , .
1 , pp .
3642 .
9 .
farmer , k. c. ( 1999 ) .
method measur monitor medic regimen adher clinic trial clinic practic .
clinic therapeut , vol .
21 , .
6 , pp .
10741090 .
10 .
hansen , r. a. , kim , m. m. , song , l. , tu , w. , wu , j. , & murray , m. d. ( 2009 ) .
adher : comparison method assess medic adher classifi nonadher .
annal pharmacotherapi , vol .
43 , .
3 , pp .
413422 .
11 .
hayn , r. b. , mcdonald , h. p. , garg , a. , & montagu , p. ( 2002 ) .
intervent help patient follow prescript medic .
cochran databas systemat review , , .
2 .
12 .
heartcycl ( 2013 ) .
http : //www.heartcycle.eu .
13 .
hivind ( 2014 ) .
https : //cordis.europa.eu/ project/rcn/90123/factsheet/en .
14 .
improvingadher ( 2015 ) .
https : //cordi .
europa.eu/project/rcn/105706/factsheet/en .
15. intern osteoporosi foundat ( 2010 ) .
osteolink .
http : //www.aal-europe.eu/projects/ tbreakosteolink/ .
16 .
maclaughlin , e. j. , raehl , c. l. , treadway , a. k. , sterl , t. l. , zoller , d. p. , & bond , c. .
( 2005 ) .
assess medic adher elder .
drug & age , vol .
22 , .
3 , pp .
231255 .
17 .
medglid ( 2018 ) .
https : //www.epill.com/ medglider.html .
18 .
medic dispens ( 2018 ) .
http : // medicaldispenser.cinfa.com .
19 .
medoclock ( 2012 ) .
http : //www.medoclock.com .
20 .
medq ( 2018 ) .
http : //lifesavingpillbox.com .
21 .
milton s. hershey medic center ( 2017 ) .
use social media improv medic adher- enc adolesc young adult sys- temic lupus .
https : //clinicaltrials.gov/ct2/ show/nct03218033 .
22 .
monarca ( 2013 ) .
https : //cordis.europa.eu/ project/rcn/93747/factsheet/en .
23 .
moreno , j. , cort , u. , garcia-gasulla , d. , gomez-sebastia , i. , & alvarez-napagao , s. ( 2013 ) .
appli coaala spider .
gibert , k. , botti , v. j. , & bolano , r. r. , editor , proc .
computacin sistema , vol .
23 , .
2 , 2019 , pp .
351363 doi : 10.13053/cys-23-2-3198 cristian barru , roger vila , antonio b. martinez , mario martn , javier vzquez salceda , rafael sim , et al.362 issn 2007-9737 16th int .
conf .
catalan associ artifici intellig , volum 256 frontier artifici intellig applic , io press , pp .
326335 .
24 .
moriski , d. , green , l. , levin , & d.w. ( 1986 ) .
concurr predict valid self-report measur medic adher .
medic care , vol .
24 , pp .
6774 .
25 .
myquest patient ( 2018 ) .
https : //myquest .
questdiagnostics.com .
26 .
nation council patient inform ed- ucat ( 2007 ) .
enhanc prescript medicin adher : nation plan .
nation council patient inform educ .
27 .
pharmaceut group european union ( 2008 ) .
target adher .
https : //www.pgeu .
eu/en/policy/5-adherence.html .
28 .
phillip ( 2018 ) .
autom medic dispens- ing servic .
https : //www.lifeline.philips.com/ pill-dispenser/health-mdp.html .
29 .
pillboxi ( 2012 ) .
http : //www.pillboxie.com .
30 .
pillo ( 2018 ) .
https : //www.pillohealth.com/ technology/ .
31 .
pullar , t. , kumar , s. , tindal , h. , & feeli , m. ( 1989 ) .
time stop count tablet ?
clinic pharmacolog & therapeut , vol .
46 , .
2 , pp .
163168 .
32 .
qualiti life follow adher therapi peopl disabl schizophrenia carer ( quatro ) ( 2004 ) .
https : //cordi .
europa.eu/project/rcn/60242/factsheet/en .
33 .
raehl , c. l. , bond , c. , wood , t. , patri , r. a. , & sleeper , r. b .
( 2002 ) .
individu drug use assess elder .
pharmacotherapi : journal human pharmacolog drug therapi , vol .
22 , .
10 , pp .
12391248 .
34 .
scheurer , d. , choudhri , n. , swanton , k. a. , matlin , o. , & shrank , w. ( 2012 ) .
associ differ type social support medic adher .
american journal manag care , vol .
18 , .
12 , pp .
e4617 .
35 .
simo , r. , ciudin , a. , simo-servat , o. , & hernandez , c. ( 2017 ) .
cognit impair dementia : new emerg complic type 2 diabetesth diabetologist  perspect .
acta diabetologica , vol .
54 , .
5 , pp .
417424 .
36 .
simon-tuv , t. , neumann , p. j. , & greenberg , d. ( 2016 ) .
cost-effect adherence-enhanc intervent : systemat review .
expert review pharmacoeconom & outcom research , vol .
16 , .
1 , pp .
6784 .
pmid : 26732615 .
37 .
smith , d. , lovel , j. , weller , c. , kennedi , b. , winbolt , m. , young , c. , & ibrahim , j .
( 2017 ) .
systemat review medic non-adher person dementia cognit impair .
plos one , vol .
12 , .
2 , pp .
119 .
38 .
control , identif deliveri prescrib medic ( medic ) ( 2004 ) .
https : //cordis.europa.eu/project/rcn/57782/ factsheet/en .
39 .
trostl , j .
( 1988 ) .
medic complianc ideolog .
social scienc & medicin , vol .
27 , pp .
1299  1308 .
40 .
world health organis ( 2003 ) .
adher long-term therapi .
evid action .
https : //www.who.int/chp/knowledge/publications/ adherence_report/en/ .
41 .
world health organis ( 2016 ) .
dementia fact sheet .
http : //www.who.int/mediacentre/factsheets/fs362/en/ .
articl receiv 20/10/2018 ; accept 10/02/2019 .
correspond author cristian barru .
computacin sistema , vol .
23 , .
2 , 2019 , pp .
351363 doi : 10.13053/cys-23-2-3198 dialcat : diabet acceler cognit impair alzheim  diseas ... 363 issn 2007-9737
